Navid RabieeNavid Rabiee graduated with an M.Sc. degree in inorganic chemistry from Shahid Beheshti University, Tehran, Iran, in 2018. During his M.Sc. research, he worked on porphyrinbased biosensors and the application of porphyrins and cobalt complexes on DyeSensitized Solar Cells (DSSC) under the supervision of Prof. Nasser Safari. At the same time, he was focused on drug delivery systems based on biocompatible and biodegradable polymers associated with different types of sensitizers, especially porphyrins, under the supervision of Prof. Mohammad Rabiee at Amirkabir University of Technology, Tehran, Iran. In 2017, he joined ANNRG to collaborate with Prof. Mahdi Karimi's Research Lab at Iran University of Medical Science, Tehran, Iran, in association with Prof. Michael R. Hamblin from Harvard Medical University, Boston, MA, working on smart microcarriers/nanocarriers applied in therapeutic agent delivery systems employed for diagnosis and therapy of various diseases and disorders such as different cancers and malignancies, inflammations, infections, etc. Currently, he is a Ph.D. candidate in inorganic chemistry at Sharif University of Technology, Tehran, Iran, and working on different types of smart nanocarriers in collaboration with Amirkabir University of Technology and Iran University of Medical Sciences. Since 2018, he has participated in a collaboration with the Global Burden of Disease (GBD) project at the University of Washington, Seattle, Washington, in association with the Institute for Health Metrics and Evaluation (IHME), and has worked on some brilliant projects that have been published in The Lancet, Nature, and other highly-cited journals. His work has resulted in the publication of over 40 peer-reviewed journal articles, 5 books, and 3 conference papers. Read More Read Less